These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3181389)

  • 1. Belgian Collaborative Study of the in-vitro susceptibility of the Bacteroides fragilis group. A Belgian Collaborative Study Group.
    Eur J Epidemiol; 1988 Sep; 4(3):360-5. PubMed ID: 3181389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of the Bacteroides fragilis group in community hospitals.
    File TM; Thomson RB; Tan JS; Salstrom SJ; Jacobs GA; Johnson L; Tan L
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):317-22. PubMed ID: 3465493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
    Betriu C; Cabronero C; Gomez M; Picazo JJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
    Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
    Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of 36 antimicrobial agents against clinically isolated Bacteroides fragilis.
    Teng LJ; Ho SW; Chang SC; Luh KT; Hsieh WC
    J Formos Med Assoc; 1991 Aug; 90(8):796-9. PubMed ID: 1683376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.
    Watanabe K; Ueno K; Kato N; Muto Y; Bandoh K; Tanaka Y; Jotwani R; Goto M; Shimada K; Shimizu K
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1069-73. PubMed ID: 1295761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.
    Cuchural GJ; Tally FP; Jacobus NV; Gorbach SL; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP
    Antimicrob Agents Chemother; 1984 Aug; 26(2):145-8. PubMed ID: 6486758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.
    Appleman MD; Heseltine PN; Cherubin CE
    Rev Infect Dis; 1991; 13(1):12-8. PubMed ID: 2017610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.
    Snydman DR; Jacobus NV; McDermott LA; Supran S; Cuchural GJ; Finegold S; Harrell L; Hecht DW; Iannini P; Jenkins S; Pierson C; Rihs J; Gorbach SL
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2417-22. PubMed ID: 10508018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J; Andrew JH
    Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of the Bacteroides fragilis group in the United States in 1981.
    Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge KE; Cleary TJ; Finegold SM; Hill GB; Iannini PB; McCloskey RV; O'Keefe JP; Pierson CL
    Antimicrob Agents Chemother; 1983 Apr; 23(4):536-40. PubMed ID: 6859833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
    Jacobs MR; Spangler SK; Appelbaum PC
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1081-93. PubMed ID: 1295763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.